• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Cano Health Inc. (Amendment)

    1/26/24 5:02:58 PM ET
    $CANO
    Medical/Nursing Services
    Health Care
    Get the next $CANO alert in real time by email
    SC 13D/A 1 d929099dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

    (Amendment No. 13)1

     

     

    Cano Health, Inc.

    (Name of Issuer)

    Class A Common Stock, $0.01 par value per share

    (Title of Class of Securities)

    13781Y103

    (CUSIP Number)

    ELLIOT COOPERSTONE

    ITC RUMBA, LLC

    One Vanderbilt Ave, Suite 2400

    New York, NY 10017

    (646) 930-1531

    CHRISTIAN WILSON, ESQ.

    AUDREY S. LEIGH, ESQ.

    GOODWIN PROCTER LLP

    620 Eighth Avenue

    New York, New York 10019

    (212) 813-8800

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    January 17, 2024

    (Date of Event Which Requires Filing of This Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐.

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    1 

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


     1   

     NAME OF REPORTING PERSONS

     

     ITC Rumba, LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     5  

     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     DELAWARE

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7    

     SOLE VOTING POWER

     

     0

        8   

     SHARED VOTING POWER

     

     580,102(1)

        9   

     SOLE DISPOSITIVE POWER

     

     0

       10   

     SHARED DISPOSITIVE POWER

     

     580,102(1)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     580,102(1)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     12.9%(2)

    14  

     TYPE OF REPORTING PERSON

     

     OO

     

    1.

    Represents 580,102 shares of Class A common stock, par value $0.01 per share (“Class A Common Stock”), of Cano Health, Inc. (the “Issuer”), after giving effect to the 1-for-100 reverse stock split which the Issuer effectuated on November 3, 2023 (the “Reverse Stock Split”). The shares of Class A Common Stock of the Issuer are held directly by ITC Rumba, LLC. Elliot Cooperstone (included below) is the Founder and Managing Partner of ITC Rumba, LLC. Therefore, Mr. Cooperstone may be deemed the beneficial owner of the shares held by ITC Rumba, LLC with voting and dispositive control over such securities.

    2.

    The percentage reported in Item 13 is based on (i) 2,887,608 shares of Class A Common Stock of the Issuer outstanding as of November 9, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on November 13, 2023, and (ii) 1,597,809 shares of Class B common stock, par value $0.01 per share (“Class B Common Stock”), of the Issuer previously converted into Class A Common Stock by ITC Rumba, LLC. Does not include 2,518,894 shares of Class B Common Stock of the Issuer outstanding as of November 9, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the SEC on November 13, 2023. Holders of Class A Common Stock and Class B Common Stock vote as a single class on all matters presented to the Company’s stockholders for their vote or approval. When calculated based upon the outstanding 2,887,608 shares of Class A Common Stock and 2,518,894 shares of Class B Common Stock outstanding as of November 13, 2023, the Reporting Person beneficially owned 10.7% of the Issuer’s Class A Common Stock and Class B Common Stock.


     1   

     NAME OF REPORTING PERSONS

     

     Elliot Cooperstone

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     OO

     5  

     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     USA

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7    

     SOLE VOTING POWER

     

     148

        8   

     SHARED VOTING POWER

     

     580,102(1)

        9   

     SOLE DISPOSITIVE POWER

     

     148

       10   

     SHARED DISPOSITIVE POWER

     

     580,102(1)

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     580,250(1)(2)

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     12.9%(3)

    14  

     TYPE OF REPORTING PERSON

     

     IN

     

    1.

    Represents 580,102 shares of Class A Common Stock of the Issuer, after giving effect to the Reverse Stock Split. The shares of Class A Common Stock of the Issuer are held directly by ITC Rumba, LLC. Mr. Cooperstone is the Founder and Managing Partner of ITC Rumba, LLC. Consequently, Mr. Cooperstone may be deemed the beneficial owner of the shares held by ITC Rumba, LLC with voting and dispositive control over such securities.

    2.

    Includes 148 shares of Class A Common Stock held directly by Mr. Cooperstone.

    3.

    The percentage reported in Item 13 is based on (i) 2,887,608 shares of Class A Common Stock of the Issuer outstanding as of November 9, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the SEC on November 13, 2023, and (ii) 1,597,809 shares of Class B Common Stock of the Issuer previously converted into Class A Common Stock by ITC Rumba, LLC. Does not include 2,518,894 shares of Class B Common Stock of the Issuer outstanding as of November 9, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the SEC on November 13, 2023. Holders of Class A Common Stock and Class B Common Stock vote as a single class on all matters presented to the Company’s stockholders for their vote or approval. When calculated based upon the outstanding 2,887,608 shares of Class A Common Stock and 2,518,894 shares of Class B Common Stock outstanding as of November 13, 2023, the Reporting Person beneficially owned 10.7% of the Issuer’s Class A Common Stock and Class B Common Stock.


    Explanatory Note

    This Amendment No. 13 (“Amendment No. 13”) amends and supplements the statement on Schedule 13D originally filed by the Reporting Person on April 4, 2023, as amended (the “Schedule 13D”). Unless otherwise indicated, each capitalized term used but not defined in this Amendment No. 13 shall have the meaning assigned to such term in the Schedule 13D.

     

    Item 5.

    Interest in Securities of the Issuer.

    Item 5 is hereby amended and restated to read as follows:

    (a)-(b) The information set forth in rows 7 through 13 of the cover pages to this Schedule 13D is incorporated by reference. The percent of class was calculated based on (i) 2,887,608 shares of Class A Common Stock outstanding as of November 9, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the SEC on November 13, 2023, and (ii) 1,597,809 shares of Class B Common Stock previously converted into Class A Common Stock by ITC Rumba, LLC. Shares of Class B Common Stock are convertible into shares of Class A Common Stock on a one-for-one basis at any time at the option of the holder.

    Mr. Cooperstone directly holds 148 shares of Class A Common Stock of the Issuer. ITC Rumba, LLC directly holds 580,102 shares of Class A Common Stock of the Issuer. Cooperstone is the Founder and Managing Partner of ITC Rumba, LLC and may be deemed the beneficial owner of the shares held by ITC Rumba, LLC with voting and dispositive control over such securities.

    (c) On each of December 15, 2023 and January 12, 2024, ITC Rumba, LLC exchanged 532,603 and 1,065,206 PCIH Common Units, respectively, together with the surrender and cancellation of the same number of shares of Class B Common Stock, for an equal number of shares of Class A Common Stock, pursuant to the Second Amended and Restated Limited Liability Company Agreement of Primary Care (ITC) Intermediate Holdings, LLC.

    None of the Reporting Persons has effected any transactions related to shares of Class A Common Stock during the past 60 days, except for the following dispositions (all of which previously have been reported or will be reported on Form 4s filed pursuant to Section 16(a) of the Act):

     

    Reporting Person Who Effected The Transaction

       Date of
    Transaction
         Number of
    Shares
         Type of
    Security
         Price
    Per
    Share(1)
         Where and How
    Transaction
    Was
    Effected
     

    ITC Rumba, LLC

         12/21/2023        89,152       

    Class A
    Common
    Stock
     
     
     
       $ 5.7340       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         12/22/2023        27,377       

    Class A
    Common
    Stock
     
     
     
       $ 5.6539       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         12/26/2023        21,154       

    Class A
    Common
    Stock
     
     
     
       $ 5.4422       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC 

         12/27/2023        37,607       

    Class A
    Common
    Stock
     
     
     
       $ 5.6471       

    Open market
    sale on
    NYSE
     
     
     


    ITC Rumba, LLC

         12/28/2023        41,197       

    Class A
    Common
    Stock
     
     
     
       $ 6.0011       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         12/29/2023        35,112       

    Class A
    Common
    Stock
     
     
     
       $ 5.9992       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/02/2024        43,505       

    Class A
    Common
    Stock
     
     
     
       $ 5.4168       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/03/2024        75,000       

    Class A
    Common
    Stock
     
     
     
       $ 4.3557       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/04/2024        13,328       

    Class A
    Common
    Stock
     
     
     
       $ 3.9989       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/05/2024        25,000       

    Class A
    Common
    Stock
     
     
     
       $ 3.8493       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/08/2024        25,000       

    Class A
    Common
    Stock
     
     
     
       $ 3.8221       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/09/2024        25,000       

    Class A
    Common
    Stock
     
     
     
       $ 3.7469       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/10/2024        25,000       

    Class A
    Common
    Stock
     
     
     
       $ 3.7317       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/11/2024        25,000       

    Class A
    Common
    Stock
     
     
     
       $ 3.5916       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/12/2024        24,171       

    Class A
    Common
    Stock
     
     
     
       $ 3.3047       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/17/2024        100,000       

    Class A
    Common
    Stock
     
     
     
       $ 2.3155       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/18/2024        100,000       

    Class A
    Common
    Stock
     
     
     
       $ 1.9125       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/22/2024        125,000       

    Class A
    Common
    Stock
     
     
     
       $ 2.5021       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/23/2024        73,034       

    Class A
    Common
    Stock
     
     
     
       $ 2.9411       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/24/2024        35,808       

    Class A
    Common
    Stock
     
     
     
       $ 2.8377       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/25/2024        18,569       

    Class A
    Common
    Stock
     
     
     
       $ 2.5828       

    Open market
    sale on
    NYSE
     
     
     

    ITC Rumba, LLC

         01/26/2024        32,693       

    Class A
    Common
    Stock
     
     
     
       $ 2.7448       

    Open market
    sale on
    NYSE
     
     
     

     

    (1) 

    The price reported is a weighted average price for shares sold in multiple transactions on the same date.


    (d) Except as described herein, to the knowledge of the Reporting Persons, only the Reporting Persons have the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, the shares of Class A Common Stock of the Issuer reported by this Schedule 13D.

    (e) Not applicable.


    SIGNATURES

    After reasonable inquiry and to the best of his or its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: January 26, 2024

     

    ITC Rumba, LLC
    By:  

    /s/ Elliot Cooperstone

      Name:   Elliot Cooperstone
      Title:   Managing Partner

     

    /s/ Elliot Cooperstone

    Elliot Cooperstone
    Get the next $CANO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CANO

    DatePrice TargetRatingAnalyst
    8/11/2023Buy → Hold
    Jefferies
    8/11/2023$4.00 → $0.80Buy → Neutral
    Citigroup
    1/6/2023$12.00 → $1.25Buy → Neutral
    UBS
    1/5/2023Outperform → Peer Perform
    Wolfe Research
    12/13/2022$1.50Underperform
    BofA Securities
    11/10/2022$10.00 → $3.00Outperform → Market Perform
    Cowen
    11/10/2022Outperform → Mkt Perform
    Raymond James
    10/27/2022$10.00 → $5.00Outperform → Neutral
    Credit Suisse
    More analyst ratings

    $CANO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cano Health downgraded by Jefferies

      Jefferies downgraded Cano Health from Buy to Hold

      8/11/23 10:23:10 AM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health downgraded by Citigroup with a new price target

      Citigroup downgraded Cano Health from Buy to Neutral and set a new price target of $0.80 from $4.00 previously

      8/11/23 7:12:10 AM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health downgraded by UBS with a new price target

      UBS downgraded Cano Health from Buy to Neutral and set a new price target of $1.25 from $12.00 previously

      1/6/23 8:53:28 AM ET
      $CANO
      Medical/Nursing Services
      Health Care

    $CANO
    Financials

    Live finance-specific insights

    See more
    • Cano Health Reschedules Second Quarter 2023 Earnings Conference Call

      MIAMI, Aug. 9, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE:CANO), announced today that it has rescheduled its second quarter 2023 earnings release and conference call to tomorrow afternoon.  A press release with the business and financial results will be issued on Thursday, August 10, 2023 after the market closes, and the Company will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results. The earnings release and call were previously scheduled for today after the market close. To access the li

      8/9/23 5:22:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health Announces Date to Report Second Quarter 2023 Results

      MIAMI, July 25, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE:CANO), a leading value-based primary care provider and population health company, will release its financial results for the second quarter 2023 after the market closes on Wednesday, August 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.  To access the live call and webcast, please dial (888) 660-6359 for U.S. participants, or (929) 203-0867 for international participants, referencing the Cano Health Second Qu

      7/25/23 4:15:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health Announces Financial Results for the First Quarter 2023

      Raises guidance for full year 2023 membership and total revenue; maintains outlook for medical cost ratio and Adjusted EBITDA Pursuing divestiture of certain non-core assets to strengthen its focus on high-performing Medicare Advantage business MIAMI, May 9, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE:CANO), a leading value-based primary care provider and population health company, today announced financial results for the first quarter ended March 31, 2023. First Quarter 2023 Financial Results Total membership of 388,667 including 207,420 Med

      5/9/23 4:05:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care

    $CANO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Cano Health Inc. (Amendment)

      SC 13G/A - Cano Health, Inc. (0001800682) (Subject)

      2/13/24 5:00:58 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13D/A filed by Cano Health Inc. (Amendment)

      SC 13D/A - Cano Health, Inc. (0001800682) (Subject)

      2/7/24 8:19:57 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by Cano Health Inc.

      SC 13G - Cano Health, Inc. (0001800682) (Subject)

      1/29/24 5:25:51 PM ET
      $CANO
      Medical/Nursing Services
      Health Care

    $CANO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan

      Emergence from Chapter 11 Expected in Third Quarter of 2024 MIAMI, May 21, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced a global agreement with the Unsecured Creditors Committee representing the interests of the Company's general unsecured creditors, with the support of the Ad Hoc Lender Group. It also received approval of its Disclosure Statement by the U.S. Bankruptcy Court for the District of Delaware (the "Court"), paving the way to solicit creditor approval of its Plan of Reorganization and its expected emergence from Chapter 11 in the third quarter. Mark

      5/21/24 5:04:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings

      MIAMI, Feb. 5, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE:CANO) ("Cano Health" or the "Company") announced today that on February 5, 2024, the New York Stock Exchange (the "NYSE") notified the Company that the NYSE had determined to (a) commence proceedings to delist the Company's Class A common stock, par value $0.01 per share ("Common Stock") and (b) immediately suspend trading in the Company's Common Stock pursuant to Section 802.01D of the NYSE Listed Company Manual after the Company filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on February 4, 2024.

      2/5/24 4:35:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health Enters Restructuring Support Agreement with a Significant Majority of its Lenders to Strengthen Financial Position

      Positions the Company to Advance Its Ongoing Transformation Plan Designed to Significantly Reduce Costs, Enhance Productivity, and Improve Cash Flow Receives Commitment for $150 Million in New Capital Ensures Patients Continue to Receive High-Quality Care Across Medical Centers MIAMI, Feb. 4, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE:CANO) ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that it has entered into a Restructuring Support Agreement (the "RSA") with lenders (the "Ad Hoc Lender Group") holding approximately 86% of its secured revolving and term loan debt and 92% of its senior unsecured notes. This a

      2/4/24 11:57:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care

    $CANO
    SEC Filings

    See more

    $CANO
    Leadership Updates

    Live Leadership Updates

    See more
    • Cano Health Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - Cano Health, Inc. (0001800682) (Filer)

      2/9/24 9:34:53 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

      8-K - Cano Health, Inc. (0001800682) (Filer)

      2/7/24 5:18:05 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • SEC Form 25-NSE filed by Cano Health Inc.

      25-NSE - Cano Health, Inc. (0001800682) (Subject)

      2/6/24 9:27:20 AM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health Announces Appointment of Two New Independent Directors

      Patricia Ferrari and Carol Flaton to Enhance the Board's and Management's Ongoing Strategic, Operational and Financing Initiatives MIAMI, Dec. 18, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE:CANO), a leading value-based primary care provider and population health company, today announced the appointment of Patricia Ferrari and Carol Flaton to its Board of Directors. Ms. Ferrari and Ms. Flaton bring broad business experience and deep financial expertise, with proven track records of advising companies on strategies to improve operations and financial performance, as well as strengthening their capital structures.

      12/18/23 4:30:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health Appoints Mark Kent Permanent Chief Executive Officer

      Mr. Kent immediately joins Board of Directors, replacing Dr. Marlow Hernandez who has stepped down MIAMI, Aug. 21, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that its Board of Directors has appointed Mark Kent as Chief Executive Officer, effective immediately. The Board also elected Mr. Kent, who has served as interim Chief Executive Officer since June 16, 2023, to Cano Health's Board of Directors. The Board also announced that Dr. Marlow Hernandez has stepped down from the Board effective immediately. Regarding Mr. Kent's appointment, the Board issued the following state

      8/21/23 8:00:00 AM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health Files Final Voting Results of Annual Stockholders' Meeting

      MIAMI, June 22, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today filed with the SEC final voting results from its Annual Stockholders' Meeting held on June 15, 2023. An aggregate of 457,462,704 shares—or 85.3% of the Company's Class A and Class B common stock outstanding as of the record date for the meeting—were represented in person or by proxy at the meeting. Cano Health's Board of Directors issued the following statement: "As previously stated, we are well aware of the significant withhold vote and we take seriously the feedback we have received from, and our duty to, our stockholders

      6/22/23 8:35:00 AM ET
      $CANO
      Medical/Nursing Services
      Health Care

    $CANO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Cooperstone Elliot sold $60,243 worth of shares (22,738 units at $2.65) (SEC Form 4)

      4 - Cano Health, Inc. (0001800682) (Issuer)

      2/2/24 6:56:35 AM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cooperstone Elliot sold $251,167 worth of shares (92,619 units at $2.71) (SEC Form 4)

      4 - Cano Health, Inc. (0001800682) (Issuer)

      1/29/24 8:07:21 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cooperstone Elliot sold $629,175 worth of shares (233,842 units at $2.69) (SEC Form 4)

      4 - Cano Health, Inc. (0001800682) (Issuer)

      1/24/24 8:07:45 PM ET
      $CANO
      Medical/Nursing Services
      Health Care